Annual Operating Expenses
$191.58 M
-$119.08 M-38.33%
31 December 2023
Summary:
Nektar Therapeutics annual total operating expenses is currently $191.58 million, with the most recent change of -$119.08 million (-38.33%) on 31 December 2023. During the last 3 years, it has fallen by -$321.78 million (-62.68%). NKTR annual operating expenses is now -64.08% below its all-time high of $533.28 million, reached on 31 December 2019.NKTR Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$53.99 M
+$3.75 M+7.47%
30 September 2024
Summary:
Nektar Therapeutics quarterly total operating expenses is currently $53.99 million, with the most recent change of +$3.75 million (+7.47%) on 30 September 2024. Over the past year, it has increased by +$8.77 million (+19.40%). NKTR quarterly operating expenses is now -62.37% below its all-time high of $143.47 million, reached on 31 March 2019.NKTR Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKTR Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.3% | +19.4% |
| 3 y3 years | -62.7% | -59.5% |
| 5 y5 years | -60.2% | -56.1% |
NKTR Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -63.4% | at low | -59.9% | +19.4% |
| 5 y | 5 years | -64.1% | at low | -60.7% | +19.4% |
| alltime | all time | -64.1% | +2325.1% | -62.4% | +616.3% |
Nektar Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $53.99 M(+7.5%) |
| June 2024 | - | $50.23 M(+5.6%) |
| Mar 2024 | - | $47.56 M(+0.6%) |
| Dec 2023 | $191.58 M(-38.3%) | $47.26 M(+4.5%) |
| Sept 2023 | - | $45.22 M(-4.9%) |
| June 2023 | - | $47.55 M(-7.8%) |
| Mar 2023 | - | $51.55 M(-9.0%) |
| Dec 2022 | $310.66 M(-40.6%) | $56.68 M(+1.0%) |
| Sept 2022 | - | $56.12 M(-11.3%) |
| June 2022 | - | $63.26 M(-53.0%) |
| Mar 2022 | - | $134.59 M(+2.2%) |
| Dec 2021 | $523.11 M(+1.9%) | $131.76 M(-1.1%) |
| Sept 2021 | - | $133.21 M(+1.8%) |
| June 2021 | - | $130.87 M(+2.8%) |
| Mar 2021 | - | $127.28 M(-2.0%) |
| Dec 2020 | $513.36 M(-3.7%) | $129.86 M(+1.8%) |
| Sept 2020 | - | $127.51 M(+5.6%) |
| June 2020 | - | $120.78 M(-10.7%) |
| Mar 2020 | - | $135.20 M(-1.7%) |
| Dec 2019 | $533.28 M(+10.9%) | $137.51 M(+11.8%) |
| Sept 2019 | - | $123.03 M(-4.8%) |
| June 2019 | - | $129.27 M(-9.9%) |
| Mar 2019 | - | $143.47 M(+8.1%) |
| Dec 2018 | $480.98 M(+49.9%) | $132.66 M(+9.1%) |
| Sept 2018 | - | $121.61 M(+12.0%) |
| June 2018 | - | $108.59 M(-8.1%) |
| Mar 2018 | - | $118.11 M(+26.0%) |
| Dec 2017 | $320.82 M(+29.3%) | $93.77 M(+20.6%) |
| Sept 2017 | - | $77.77 M(+2.0%) |
| June 2017 | - | $76.26 M(+4.4%) |
| Mar 2017 | - | $73.03 M(+15.9%) |
| Dec 2016 | $248.08 M(+9.7%) | $62.99 M(+1.3%) |
| Sept 2016 | - | $62.20 M(-1.9%) |
| June 2016 | - | $63.38 M(+6.5%) |
| Mar 2016 | - | $59.50 M(-1.4%) |
| Dec 2015 | $226.05 M(+19.8%) | $60.37 M(+14.4%) |
| Sept 2015 | - | $52.77 M(-5.1%) |
| June 2015 | - | $55.60 M(-3.0%) |
| Mar 2015 | - | $57.31 M(+13.0%) |
| Dec 2014 | $188.66 M(-18.2%) | $50.74 M(+17.1%) |
| Sept 2014 | - | $43.33 M(-6.5%) |
| June 2014 | - | $46.32 M(-4.0%) |
| Mar 2014 | - | $48.27 M(-16.9%) |
| Dec 2013 | $230.54 M(+21.2%) | $58.08 M(+6.5%) |
| Sept 2013 | - | $54.56 M(-11.2%) |
| June 2013 | - | $61.46 M(+8.9%) |
| Mar 2013 | - | $56.45 M(-1.4%) |
| Dec 2012 | $190.29 M(+9.7%) | $57.24 M(+29.8%) |
| Sept 2012 | - | $44.08 M(+1.4%) |
| June 2012 | - | $43.47 M(-4.5%) |
| Mar 2012 | - | $45.50 M(+1.6%) |
| Dec 2011 | $173.53 M(+16.4%) | $44.80 M(+3.3%) |
| Sept 2011 | - | $43.37 M(-0.2%) |
| June 2011 | - | $43.45 M(+3.7%) |
| Mar 2011 | - | $41.90 M(-2.6%) |
| Dec 2010 | $149.05 M(+9.5%) | $43.04 M(+13.5%) |
| Sept 2010 | - | $37.91 M(+5.9%) |
| June 2010 | - | $35.81 M(+10.9%) |
| Mar 2010 | - | $32.30 M(-9.5%) |
| Dec 2009 | $136.12 M | $35.70 M(+8.3%) |
| Sept 2009 | - | $32.95 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2009 | - | $33.09 M(-3.8%) |
| Mar 2009 | - | $34.38 M(-428.8%) |
| Dec 2008 | $136.34 M(-15.7%) | -$10.46 M(-120.6%) |
| Sept 2008 | - | $50.65 M(+8.2%) |
| June 2008 | - | $46.83 M(-5.1%) |
| Mar 2008 | - | $49.32 M(+1035.3%) |
| Dec 2007 | $161.66 M(-37.5%) | $4.34 M(-91.0%) |
| Sept 2007 | - | $48.44 M(-11.0%) |
| June 2007 | - | $54.41 M(-0.1%) |
| Mar 2007 | - | $54.46 M(-21.0%) |
| Dec 2006 | $258.86 M(-6.7%) | $68.92 M(+37.5%) |
| Sept 2006 | - | $50.13 M(-42.1%) |
| June 2006 | - | $86.66 M(+63.1%) |
| Mar 2006 | - | $53.14 M(-60.6%) |
| Dec 2005 | $277.32 M(+64.7%) | $134.87 M(+167.0%) |
| Sept 2005 | - | $50.52 M(+7.7%) |
| June 2005 | - | $46.90 M(+4.1%) |
| Mar 2005 | - | $45.04 M(+3.0%) |
| Dec 2004 | $168.41 M(+6.8%) | $43.71 M(+1.9%) |
| Sept 2004 | - | $42.90 M(-0.0%) |
| June 2004 | - | $42.91 M(+9.7%) |
| Mar 2004 | - | $39.10 M(-8.5%) |
| Dec 2003 | $157.76 M(-16.0%) | $42.73 M(+12.6%) |
| Sept 2003 | - | $37.95 M(-1.8%) |
| June 2003 | - | $38.64 M(+0.5%) |
| Mar 2003 | - | $38.45 M(-23.7%) |
| Dec 2002 | $187.91 M(+2.1%) | $50.36 M(+9.8%) |
| Sept 2002 | - | $45.86 M(+6.0%) |
| June 2002 | - | $43.25 M(-10.7%) |
| Mar 2002 | - | $48.44 M(-11.6%) |
| Dec 2001 | $184.00 M(+59.3%) | $54.78 M(+12.0%) |
| Sept 2001 | - | $48.92 M(+13.9%) |
| June 2001 | - | $42.94 M(+14.9%) |
| Mar 2001 | - | $37.37 M(+20.6%) |
| Dec 2000 | $115.48 M(+60.5%) | $30.98 M(+3.3%) |
| Sept 2000 | - | $30.00 M(+3.1%) |
| June 2000 | - | $29.09 M(+14.5%) |
| Mar 2000 | - | $25.40 M(+9.7%) |
| Dec 1999 | $71.95 M(+64.3%) | $23.15 M(+26.5%) |
| Sept 1999 | - | $18.30 M(+10.9%) |
| June 1999 | - | $16.50 M(+18.0%) |
| Mar 1999 | - | $13.98 M(+6.0%) |
| Dec 1998 | $43.78 M(+46.1%) | $13.19 M(+23.2%) |
| Sept 1998 | - | $10.70 M(+0.3%) |
| June 1998 | - | $10.67 M(+16.7%) |
| Mar 1998 | - | $9.14 M(+0.6%) |
| Dec 1997 | $29.97 M(+52.9%) | $9.09 M(+16.9%) |
| Sept 1997 | - | $7.77 M(+8.5%) |
| June 1997 | - | $7.16 M(+20.9%) |
| Mar 1997 | - | $5.92 M(-17.8%) |
| Dec 1996 | $19.60 M(+47.4%) | $7.20 M(+60.0%) |
| Sept 1996 | - | $4.50 M(+2.3%) |
| June 1996 | - | $4.40 M(+22.2%) |
| Mar 1996 | - | $3.60 M(-18.2%) |
| Dec 1995 | $13.30 M(+68.4%) | $4.40 M(+46.7%) |
| Sept 1995 | - | $3.00 M(0.0%) |
| June 1995 | - | $3.00 M(+3.4%) |
| Mar 1995 | - | $2.90 M(-55.4%) |
| Dec 1994 | $7.90 M | $6.50 M(+983.3%) |
| Sept 1994 | - | $600.00 K(+50.0%) |
| June 1994 | - | $400.00 K(0.0%) |
| Mar 1994 | - | $400.00 K |
FAQ
- What is Nektar Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Nektar Therapeutics?
- What is Nektar Therapeutics annual operating expenses year-on-year change?
- What is Nektar Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Nektar Therapeutics?
- What is Nektar Therapeutics quarterly operating expenses year-on-year change?
What is Nektar Therapeutics annual total operating expenses?
The current annual operating expenses of NKTR is $191.58 M
What is the all time high annual operating expenses for Nektar Therapeutics?
Nektar Therapeutics all-time high annual total operating expenses is $533.28 M
What is Nektar Therapeutics annual operating expenses year-on-year change?
Over the past year, NKTR annual total operating expenses has changed by -$119.08 M (-38.33%)
What is Nektar Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of NKTR is $53.99 M
What is the all time high quarterly operating expenses for Nektar Therapeutics?
Nektar Therapeutics all-time high quarterly total operating expenses is $143.47 M
What is Nektar Therapeutics quarterly operating expenses year-on-year change?
Over the past year, NKTR quarterly total operating expenses has changed by +$8.77 M (+19.40%)